Suppr超能文献

奥地利有多少女性在怀孕期间口服补充剂?:是谁推荐的?一项横断面研究。

How many women take oral supplementation in pregnancy in Austria? : Who recommended it? A cross-sectional study.

机构信息

Institute of General Practice and Evidence-based Health Services Research, Medical University of Graz, Auenbruggerplatz 20/III, 8036, Graz, Austria.

Institute for Medical Informatics, Statistics and Documentation, Medical University of Graz, Graz, Austria.

出版信息

Wien Klin Wochenschr. 2019 Oct;131(19-20):462-467. doi: 10.1007/s00508-019-1502-9. Epub 2019 May 16.

Abstract

BACKGROUND

Iron deficiency anemia is common in pregnancy with a prevalence of approximately 16% in Austria; however, international guideline recommendations on screening and subsequent treatment with iron preparations are inconsistent. The aim of this study was to find out how often pregnant women take iron-containing supplements, and who recommended them. As hemoglobin data were available for a sub-group of women, hemoglobin status during pregnancy and associated consumption of iron-containing medications were also recorded.

METHODS

This cross-sectional study was conducted at the Mother-Child-Booklet service center of the Styrian Health Insurance Fund in Graz, Austria. A questionnaire containing seven questions was developed. Absolute and relative numbers were determined, and corresponding 95% confidence intervals calculated using bootstrapping techniques.

RESULTS

A total of 325 women completed the questionnaire, 11% had been diagnosed with anemia before becoming pregnant, 67% reported taking iron-containing compounds. The women reported taking 45 different products but 61% took 1 of 3 different supplements. Overall, 185 (57%) women had not been diagnosed with anemia before becoming pregnant but reported taking an iron-containing supplement and 89% of the women took supplements on the recommendation of their physician. Of the 202 women whose hemoglobin status was assessed, 92% were found not to be anemic.

CONCLUSION

Overall, 67% of pregnant women took iron-containing compounds, irrespective of whether they were deficient in iron. Physicians were generally responsible for advising them to take them. No standardized procedure is available on which to base the decision whether to take iron during pregnancy, even in guidelines. As most guidelines only recommend taking iron supplements in cases of anemia, the high percentage of women taking them in Austria is incomprehensible.

摘要

背景

缺铁性贫血在妊娠中很常见,在奥地利的患病率约为 16%;然而,国际指南建议对其进行筛查,并随后用铁制剂进行治疗,这些建议并不一致。本研究旨在了解孕妇服用含铁补充剂的频率,以及谁推荐了这些补充剂。由于对一部分女性的血红蛋白数据可用,因此还记录了妊娠期间的血红蛋白状况以及与含铁药物的相关消耗。

方法

这是一项在奥地利施蒂里亚健康保险基金的母婴手册服务中心进行的横断面研究。开发了一个包含七个问题的问卷。使用自举技术确定绝对和相对数量,并计算相应的 95%置信区间。

结果

共有 325 名女性完成了问卷,11%的女性在怀孕前被诊断为贫血,67%的女性报告服用了含铁化合物。女性报告服用了 45 种不同的产品,但 61%的人服用了 3 种不同的补充剂之一。总体而言,185 名(57%)女性在怀孕前未被诊断为贫血,但报告服用了含铁补充剂,89%的女性根据医生的建议服用了补充剂。在评估了血红蛋白状况的 202 名女性中,92%的女性未被诊断为贫血。

结论

总体而言,67%的孕妇服用了含铁化合物,无论她们是否缺铁。医生通常负责建议她们服用。即使在指南中,也没有可用于确定是否在怀孕期间服用铁的标准化程序。由于大多数指南仅建议在贫血的情况下服用铁补充剂,因此奥地利的高比例的女性服用这些补充剂是不可理解的。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验